[HTML][HTML] Safety and efficacy of NVX-CoV2373 Covid-19 vaccine

…, R Smith, RL Soiza, PA Swift… - … England Journal of …, 2021 - Mass Medical Soc
Background Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a
recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (…

Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a …

…, J Galloway, AL Goodman, PA Swift… - The Lancet …, 2022 - thelancet.com
Background The safety and immunogenicity profile of COVID-19 vaccines when administered
concomitantly with seasonal influenza vaccines have not yet been reported. We therefore …

Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: a randomized control trial

PA Swift, ND Markandu, GA Sagnella, FJ He… - …, 2005 - Am Heart Assoc
High blood pressure and proteinuria are the major risk factors for cardiovascular and renal
disease. In black individuals, there is an increased risk of hypertension, stroke, heart failure, …

Safety and efficacy of the NVX-CoV2373 coronavirus disease 2019 vaccine at completion of the placebo-controlled phase of a randomized controlled trial

…, R Smith, RL Soiza, PA Swift… - Clinical Infectious …, 2023 - academic.oup.com
Background The recombinant protein-based vaccine, NVX-CoV2373, demonstrated 89.7%
efficacy against coronavirus disease 2019 (COVID-19) in a phase 3, randomized, observer-…

Sodium‐glucose cotransporter‐2 inhibitors and kidney outcomes in real‐world type 2 diabetes populations: A systematic review and meta‐analysis of observational …

…, NI Cole, S de Lusignan, PA Swift - Diabetes, Obesity …, 2023 - Wiley Online Library
Pauline Swift has received honoraria for presentations from AstraZeneca and Bayer, financial
support from Bayer to attend the American Society of Nephrology Conference, 2022, and …

Nocturnal blood pressure and progression to end-stage renal disease or death in nondiabetic chronic kidney disease stages 3 and 4

J Redon, E Plancha, PA Swift, S Pons… - Journal of …, 2010 - journals.lww.com
Objective The objective was to assess the role of office and ambulatory blood pressure (BP)
on the development of end-stage renal disease (ESRD) in nondiabetic chronic renal failure. …

Efficacy of the NVX-CoV2373 Covid-19 vaccine against the B. 1.1. 7 variant

…, D Saralaya, RP Sheridan, R Smith, RL Soiza, PA Swift… - MedRxiv, 2021 - medrxiv.org
Background Covid-19 vaccines are urgently needed, especially against emerging variants.
NVX-CoV2373 is a recombinant severe acute respiratory syndrome coronavirus 2 (SARS-…

[HTML][HTML] The health impacts of dietary sodium and a low-salt diet

RJ Suckling, PA Swift - Clinical medicine, 2015 - ncbi.nlm.nih.gov
High salt intake is now endemic worldwide. It contributes to the generation and maintenance
of high blood pressure, which is now the biggest risk factor for global disease. There is now …

Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study

…, WL Hall, AG Patel, RM Blacklock, PA Swift… - American journal of …, 2014 - ajkd.org
A 61-year-old woman was admitted to our hospital with general fatigue. Laboratory tests
showed kidney failure, and imaging showed visceral inversion with polycystic liver and kidneys (…

The effect of dietary salt on blood pressure in individuals receiving chronic dialysis: a systematic review and meta-analysis of randomised controlled trials

NI Cole, PA Swift, FJ He, GA MacGregor… - Journal of Human …, 2019 - nature.com
Dietary salt reduction in the general population lowers blood pressure and cardiovascular
risk. Despite being widely recommended, there is limited evidence as to whether this is …